Reuters Events | Pharma

Thought leadership and innovation for the Pharmaceutical Industry

As the Big Pharmas merge (and therefore look for synergies by axing thousands of jobs) or lay off massively to preserve earnings, the ensuing exodus of staff of all ages and from each and every functi

As the Big Pharmas merge (and therefore look for synergies by axing thousands of jobs) or lay off massively to preserve earnings, the ensuing exodus of staff of all ages and from each and every function fills the in-baskets of search firms and swells the ranks of the unemployed.

The search firms lament that they can't deal with this inflow that they describe as a tsunami of historical proportions. Because job offers are rare... And because smaller companies do not have the potential or the cash (or both) to absorb more than a fraction of this tidal wave.

Yet, there are some nuggets in the middle of all this gravel.

In fact, as most of these people suffer psychologically (some are almost reaching the stage of PTSD) and are not suited for smaller and more entrepreneurial environments, a few others are ready to roll up their sleeves and genuinely try another business model.

The gold rush is starting... But the gold diggers are the small companies, not the hordes of would be candidates.